These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart. Gralinski MR; Park JL; Ozeck MA; Wiater BC; Lucchesi BR J Pharmacol Exp Ther; 1997 Aug; 282(2):554-60. PubMed ID: 9262315 [TBL] [Abstract][Full Text] [Related]
3. The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart. Kilgore KS; Naylor KB; Tanhehco EJ; Park JL; Booth EA; Washington RA; Lucchesi BR J Pharmacol Exp Ther; 1998 Jun; 285(3):987-94. PubMed ID: 9618399 [TBL] [Abstract][Full Text] [Related]
4. Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart. Hong TT; White AJ; Lucchesi BR Int Immunopharmacol; 2005 Feb; 5(2):381-91. PubMed ID: 15652767 [TBL] [Abstract][Full Text] [Related]
5. Effects of complement activation in the isolated heart. Role of the terminal complement components. Homeister JW; Satoh P; Lucchesi BR Circ Res; 1992 Aug; 71(2):303-19. PubMed ID: 1628389 [TBL] [Abstract][Full Text] [Related]
6. Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. Homeister JW; Satoh PS; Kilgore KS; Lucchesi BR J Immunol; 1993 Feb; 150(3):1055-64. PubMed ID: 8423331 [TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage. Gralinski MR; Wiater BC; Assenmacher AN; Lucchesi BR Immunopharmacology; 1996 Sep; 34(2-3):79-88. PubMed ID: 8886851 [TBL] [Abstract][Full Text] [Related]
8. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury. Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695 [TBL] [Abstract][Full Text] [Related]
9. Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. Friedrichs GS; Kilgore KS; Manley PJ; Gralinski MR; Lucchesi BR Circ Res; 1994 Oct; 75(4):701-10. PubMed ID: 7923616 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo inhibition of complement activity by a single-chain Fv fragment recognizing human C5. Evans MJ; Rollins SA; Wolff DW; Rother RP; Norin AJ; Therrien DM; Grijalva GA; Mueller JP; Nye SH; Squinto SP Mol Immunol; 1995 Nov; 32(16):1183-95. PubMed ID: 8559143 [TBL] [Abstract][Full Text] [Related]
11. Role of tissue factor-mediated coagulation in ischemia/ reperfusion-induced injury of Langendorf-perfused rabbit hearts. Armaganian L; Kam G; Eisenberg PR; Schechtman KB; Abendschein DR Coron Artery Dis; 2000 Sep; 11(6):481-7. PubMed ID: 10966134 [TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy. Pross M; Lippert H; Misselwitz F; Nestler G; Krüger S; Langer H; Halangk W; Schulz HU Thromb Res; 2003 Jun; 110(4):215-20. PubMed ID: 14512085 [TBL] [Abstract][Full Text] [Related]
13. CD59 prevents human complement-mediated injuries in isolated guinea pig hearts. Wu S; Ma H; Huang S; Dong Y; Wu C; Shun J Chin Med J (Engl); 2002 Feb; 115(2):175-8. PubMed ID: 11940325 [TBL] [Abstract][Full Text] [Related]
14. Heat stress protects the perfused rabbit heart from complement-mediated injury. Gralinski MR; Black SC; Stancato LF; Kilgore KS; Campau PA; Park JL; Ozeck MJ; Pratt WB; Lucchesi BR Am J Physiol; 1996 Aug; 271(2 Pt 2):H571-8. PubMed ID: 8770098 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion. Kilgore KS; Tanhehco EJ; Naylor KB; Lucchesi BR J Pharmacol Exp Ther; 1999 Sep; 290(3):1041-7. PubMed ID: 10454476 [TBL] [Abstract][Full Text] [Related]
16. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Gralinski MR; Black SC; Kilgore KS; Chou AY; McCormack JG; Lucchesi BR Cardiovasc Res; 1994 Aug; 28(8):1231-7. PubMed ID: 7954626 [TBL] [Abstract][Full Text] [Related]
18. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Väkevä A; Morgan BP; Tikkanen I; Helin K; Laurila P; Meri S Am J Pathol; 1994 Jun; 144(6):1357-68. PubMed ID: 7515561 [TBL] [Abstract][Full Text] [Related]
19. Prolonged support of working rabbit hearts using Fluosol-43 or erythrocyte media. Segel LD; Ensunsa JL; Boyle WA Am J Physiol; 1987 Feb; 252(2 Pt 2):H349-59. PubMed ID: 3812749 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologic validation of the clinical effects of an optimized low-molecular-weight heparin-reviparin. Fareed J; Jeske W; Eschenfelder V; Iqbal O; Hoppensteadt D; Ahsan A Semin Thromb Hemost; 1995; 21(2):212-27. PubMed ID: 7660144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]